================================================================================
CLINICAL TRIALS MATCHING REPORT
================================================================================

Patient ID: 2
Diagnosis: NET des Dünndarms mit Lymphknoten und Lebermetastasen (ED 2015)
Koloskopie bei unklaren abdominellen Beschwerden 06/2015: Tumor im Ileum 25 cm oberhalb der Ileozökalklappe. G3 NET, Ki67 48%.
07/2015 CT staging Thorax/Abdomen: Primärtumor des Ileums 40 x 40 x 70 mm. V.a. Lymphknotenmetastasen lokoregionär. V.a. Lebermetastasen in Segment VI und VIII.

07/2015 Hemicolektomie rechts und Ileumteilresektion mit Lymphadenektomie.
Clinical Question: Weitere Therapie?
Report generated: 2025-07-08 15:16:59

Found 2 relevant clinical trials
--------------------------------------------------------------------------------

1. "Receptor Radionuclide Therapy With 177Lu-DOTATOC
   NCT ID: NCT06045260
   Status: RECRUITING
   Phase: PHASE2
   Relevance Score: 0.900
   Relevance Reason: Die Studie ist hochrelevant für den Patienten.
   Condition: Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma
   Intervention: 177Lu-DOTATOC
   Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
   Start Date: 2023-09-13
   Completion Date: 2027-01
   Locations: AUSL Romagna - Ospedale "M. Bufalini", Cesena, Italy; IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l., Meldola, Italy
   URL: https://clinicaltrials.gov/study/NCT06045260
----------------------------------------

2. 68Ga-DOTATOC Radio-Guided Surgery With β-Probe in GEP-NET
   NCT ID: NCT05448157
   Status: ACTIVE_NOT_RECRUITING
   Phase: N/A
   Relevance Score: 0.600
   Relevance Reason: Die Studie untersucht die Radio-Guided Surgery mit 68Ga-DOTATOC bei GEP-NETs.
   Condition: Neuroendocrine Tumor Carcinoid; Neuroendocrine Tumor of Pancreas; Gep Net
   Intervention: 
   Sponsor: European Institute of Oncology
   Start Date: 2022-05-12
   Completion Date: 2023-12-12
   Locations: IRCCS Istituto Europeo di Oncologia S.r.l., Milan, Italy
   URL: https://clinicaltrials.gov/study/NCT05448157
----------------------------------------